{
  "variant": {
    "gene": "LRRK2",
    "protein_change": "I2020T",
    "position": "2020",
    "reference_allele": "I",
    "alternative_allele": "T",
    "variant_string_id": "LRRK2 I2020T"
  },
  "acmg_flowchart": {
    "step_1": {
      "definition_of_disease_mechanism": "The paper establishes that LRRK2 is the causal gene for Parkinson's disease, with the I2020T mutation leading to increased susceptibility to proteasomal degradation, which impairs its protective role against apoptosis."
    },
    "step_2": {
      "applicability_of_assay": "The apoptosis and proteolysis assays directly test the functional impact of the I2020T mutation on LRRK2's protective role, which is central to the disease mechanism."
    },
    "step_3": {
      "step_3a": {
        "basic_controls_and_replicates": "The abstract mentions wild-type LRRK2 as a control and proteolysis inhibitor experiments, but does not explicitly describe replicates or statistical methods."
      },
      "step_3b": {
        "accepted_validated_assay": "The apoptosis and proteolysis assays are standard in the field, but the paper does not cite prior validation or mention commercial kits."
      },
      "step_3c": {
        "variant_controls": "No known pathogenic or benign variants are explicitly used as controls in the study."
      }
    },
    "step_4": {
      "step_4a": {
        "statistical_analyses": "The abstract does not mention p-values, effect sizes, or OddsPath calculations."
      },
      "step_4b": {
        "number_of_controls": "Only the I2020T mutant and wild-type LRRK2 are tested, resulting in fewer than 10 controls."
      },
      "step_4c": {
        "oddspath_correlation": "No OddsPath values are reported, but the functional impairment of I2020T suggests pathogenicity."
      }
    },
    "functional_evidence_aim": "Pathogenic",
    "evidence_strength": "PS3_supporting"
  }
}